Journals / Turkish Journal of Gastroenterology / 2002 / Cilt: 13 - Sayı: 4

Alverine bağlı toksik hepatit: Olgu sunumu

Alverine induced toxic hepatitis: A case report

Pages
226–228
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We present the case of a patient with alverine induced hepatotoxicity and cholestasis, which has only seldomly been reported in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Drug-induced hepatotoxicity is an important cause of hepatocellular injury.
📊
Key Findings & Data:Hepatic necrosis may range from asymptomatic elevations in transaminases to fulminant hepatic failure and death.
💡
Conclusion & Impact:We present the case of a patient with alverine induced hepatotoxicity and cholestasis, which has only seldomly been reported in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hepatit · toksik · Orta Yaş

Abstract

Drug-induced hepatotoxicity is an important cause of hepatocellular injury. Hepatic necrosis may range from asymptomatic elevations in transaminases to fulminant hepatic failure and death. Alverine is an antispasmodic drug which is especially used in patients with irritable bowel syndrome. Only a few cases of alverine associated hepatotoxicity have been reported previously. We present the case of a patient with alverine induced hepatotoxicity and cholestasis, which has only seldomly been reported in the literature.

Özet

İlaca bağlı hepatotoksisite hepatosellüler hasarın önemli nedenlerinden biridir. Hepatik nekroz hafif transaminaz yüksekliklerinden fulminan hepatite ve ölüme kadar değişen derecelerde olabilir. Alverine, özellikle irritabl barsak sendromu olan hastalarda anti-spazmodik olarak kullanılmaktadır. Alverine'e bağlı hepatotoksisite çok nadir bildirilmiştir. Alverine'e bağlı akut hepatit ve kolestazla seyreden toksik hepatit olgumuz, literatürde bu tür vakaların çok nadir olması nedeni ile ilginç bulunarak sunulmuştur.

🔖

Cite This Article

DURAKOĞLU, Z., BOZTAŞ, G., SEZGİL, A., KAYMAKOĞLU, S., DİNÇER, D., ÖZDİL, S., BEŞIŞIK, F., MUNGAN, Z., ÖKTEN, A. (2002). Alverine bağlı toksik hepatit: Olgu sunumu. Turkish Journal of Gastroenterology, Cilt: 13 - Sayı: 4, 226–228. https://ajindex.com/articles/410433

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Pessayre D, Larrey D. Drug-induced liver injury. In: McIntrye N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, editors. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press; 1992. pp. 875-902
  2. Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis 2002; 22: 145-55
  3. Malka D, Pham BN, Courvalin JC, et al. Acute hepatitis caused by alverine associated with anti-lamin A and C autoantibodies. J Hepatol 1997;27: 399-403
  4. Kaplowitz N. Biochemical and cellular mechanisms of toxic liver injury. Semin Liver Dis 2002;22:137-44
  5. Homberg JC, Abuaf N, Helmy KS et al. Drug-induced hepatitis associated with anticytoplasmic organella autoantibodies. Hepatology 1985;5:722-7
  6. Bourdi M, Larrey D, Nataf J, et al. Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-4501A2. J Clin Invest 1990;85:1967-73
  7. Iwarson S, Lindberg J, Lunden P. Nitrofurantoin-induced chronic liver disease. Clinical course and outcome of five cases. Scand J Gastroenterol 1979;14:497-500
  8. Danan G. Consensus meetings on causality assessment of drug-induced liver injury. J Hepatol 1988;7:132-6
  9. Poncin E, Sylvain C, Touchard G, et al. Papaverine-induced chronic liver disease. Gastroenterology 1986; 90: 1051-3.